| First Author | Kim J | Year | 2019 |
| Journal | Cancer Cell | Volume | 35 |
| Issue | 2 | Pages | 191-203.e8 |
| PubMed ID | 30712844 | Mgi Jnum | J:271167 |
| Mgi Id | MGI:6279332 | Doi | 10.1016/j.ccell.2018.12.012 |
| Citation | Kim J, et al. (2019) Wild-Type p53 Promotes Cancer Metabolic Switch by Inducing PUMA-Dependent Suppression of Oxidative Phosphorylation. Cancer Cell 35(2):191-203.e8 |
| abstractText | The tumor suppressor p53 is somatically mutated in half of all human cancers. Paradoxically, the wild-type p53 (WTp53) is often retained in certain human cancers, such as hepatocarcinoma (HCC). We discovered a physiological and oncogenic role of WTp53 in suppressing pyruvate-driven oxidative phosphorylation by inducing PUMA. PUMA inhibits mitochondrial pyruvate uptake by disrupting the oligomerization and function of mitochondrial pyruvate carrier (MPC) through PUMA-MPC interaction, which depends on IkappaB kinase-mediated phosphorylation of PUMA at Ser96/106. High expression levels of PUMA are correlated with decreased mitochondrial pyruvate uptake and increased glycolysis in HCCs and poor prognosis of HCC patients. These findings are instrumental for cancer drug discovery aiming at activating WTp53 or restoring WTp53 activity to p53 mutants. |
